[SCHEDULE 13G/A] agilon health, inc. SEC Filing

Rhea-AI Filing Summary

Capital World Investors reports a material stake in agilon health. The filing discloses beneficial ownership of 45,570,601 shares of agilon health common stock, equal to 11.0% of the 413,951,779 shares believed outstanding. The filer reports sole voting and sole dispositive power over all reported shares.

The disclosure identifies Capital World Investors as a division of Capital Research and Management Company together with its investment management subsidiaries and affiliates that collectively provide investment services under the Capital World Investors name. The statement affirms the securities are held in the ordinary course of business and are not held to change or influence control of the issuer. Item 6 lists American Funds Fundamental Investors in the context of ownership on behalf of another person.

Positive

• Large, clearly disclosed position: 45,570,601 shares represent 11.0% of outstanding stock, a material institutional stake.
• Sole voting and dispositive power: The filer reports exclusive authority to vote and dispose of the reported shares, providing clarity on voting control.
• Held in ordinary course: The filer certifies the securities are held in the ordinary course of business and not to change control, consistent with passive institutional ownership.

Negative

• None.

Insights

Financial Analyst

TL;DR: Capital World Investors holds an 11.0% stake and has sole voting and dispositive power over 45.6M agilon health shares.

This Schedule 13G/A is a routine but material institutional disclosure showing CWI as a significant shareholder with exclusive control of voting and disposition for the reported position. An 11.0% stake in a mid-cap issuer is large enough to be relevant to shareholder composition and may influence market perception of investor base and potential voting outcomes, even though the filer states the shares are held in the ordinary course and not to affect control.

Corporate Governance Expert

TL;DR: CWI reports sole control over 11.0% of shares but certifies holdings are not for control purposes.

The filing documents sole voting and dispositive authority for the full reported position, which concentrates actionable voting power for this institutional investor. The explicit certification that the holdings are not intended to influence control is standard for a Schedule 13G filing and signals passive institutional ownership rather than an activist approach. Item 6 naming American Funds Fundamental Investors should be noted as an instance of holdings held on behalf of others.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 6)

agilon health, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

00857U107

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 00857U107

1

Names of Reporting Persons

Capital World Investors

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 45,570,601.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 45,570,601.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

45,570,601.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

11.0 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: agilon health, Inc.
(b)	Address of issuer's principal executive offices: 440 Polaris Parkway, Suite 550, Westerville, OH 43082
Item 2.
(a)	Name of person filing: Capital World Investors
(b)	Address or principal business office or, if none, residence: 333 SOUTH HOPE STREET, 55TH FLOOR, LOS ANGELES, CALIFORNIA 90071
(c)	Citizenship: N/A
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 00857U107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 45,570,601 ** **Capital World Investors ("CWI") is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CWI's divisions of each of the investment management entities collectively provide investment management services under the name "Capital World Investors." CWI is deemed to be the beneficial owner of 45,570,601 shares or 11.0% of the 413,951,779 shares believed to be outstanding.
(b)	Percent of class: 11.0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 45,570,601
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 45,570,601
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. American Funds Fundamental Investors
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Capital World Investors

Signature:	Timothy J. Moon
Name/Title:	Vice President and Senior Counsel, Capital Research and Management Company
Date:	08/04/2025

FAQ

How many agilon health (AGL) shares does Capital World Investors own?

45,570,601 shares, representing 11.0% of the 413,951,779 shares believed outstanding, as reported in the filing.

Does Capital World Investors have voting control over its agilon health shares?

Yes. The filing reports sole voting power and sole dispositive power over the 45,570,601 shares.

Is Capital World Investors holding the shares to influence control of agilon health (AGL)?

The filing certifies the securities are held in the ordinary course of business and were not acquired to change or influence control of the issuer.

Who is Capital World Investors as described in the filing?

The filing states Capital World Investors is a division of Capital Research and Management Company and includes related investment management subsidiaries and affiliates acting collectively under that name.

Does the filing indicate holdings on behalf of other investors?

Item 6 lists American Funds Fundamental Investors, indicating holdings are, in part, associated with another named investor group.